2018 Pan Pacific Lymphoma Conference

 

2018 Pan Pacific Lymphoma Conference
A

Hodgkin Lymphoma German Hodgkin Study Group Upfront Therapy

By 2018 Pan Pacific Lymphoma Conference FEATURING Andreas Engert
By 2018 Pan Pacific Lymphoma Conference FEATURING Andreas Engert
0 views
October 2, 2018
Comments 0
Login to view comments. Click here to Login

Featured Video

08:18
Insights from 2023 ASH Annual Meeting

Treatment Strategies for Hematocrit Control in PV

Feat. A. Zhou

Featured Video

24:44
Indy Hematology Review

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray
Hodgkin Lymphoma
20:26
2018 Pan Pacific Lymphoma Conference

Radiation Therapy for nondular lymphocyte predominant Hodgkin Lympho…

Feat. R. Hoppe
10:00
2018 Pan Pacific Lymphoma Conference

Relapsed and Primary Refractory Hodgkin Lymphoma in the Near Future

Feat. C. Moskowitz
15:48
2018 Pan Pacific Lymphoma Conference

Evalutation of patients for ASCT in Relapsed Refractory Hodgkin Lymp…

Feat. C. Moskowitz
21:11
2018 Pan Pacific Lymphoma Conference

Use of Total Metabolic Tumor Volume in PET Scans

Feat. N. Hansen
06:45
2018 Pan Pacific Lymphoma Conference

Hodgkin Lymphoma: First Relapse Options

Feat. B. Pro
16:04
2018 Pan Pacific Lymphoma Conference

Beyond Standard Chemotherapy Novel Agents and Appraoches in HL

Feat. B. Pro
20:54
2018 Pan Pacific Lymphoma Conference

Beyond Checkpoint Inhibitors for Hodgkin Lymphoma

Feat. S. Ansell
14:48
2018 Pan Pacific Lymphoma Conference

Hodgkin Lymphoma German Hodgkin Study Group Upfront Therapy

Feat. A. Engert